UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): October 21, 2004
EDWARDS LIFESCIENCES CORPORATION
(Exact name of registrant as specified in its charter)
Delaware |
| 1-15525 |
| 36-4316614 |
(State or other jurisdiction |
| (Commission |
| (IRS Employer |
|
|
|
|
|
One Edwards Way, Irvine, California |
| 92614 | ||
(Address of principal executive offices) |
| (Zip Code) | ||
| ||||
(949) 250-2500 | ||||
Registrant’s telephone number, including area code | ||||
| ||||
N/A | ||||
(Former Name or Former Address, if Changed Since Last Report) | ||||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02. Results of Operations and Financial Condition.
This information furnished under this Item 2.02, including Exhibit 99.1 shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) except that the information contained in the first two paragraphs of Exhibit 99.1 and pages 7 through 13, inclusive, shall be considered to be filed under the Exchange Act.
On October 21, 2004, Edwards Lifesciences Corporation, a Delaware corporation (“Edwards”), issued a press release setting forth Edwards’ financial results for the third quarter of 2004. A copy of the press release is attached as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits.
(c) Exhibits
99.1 Press release, dated October 21, 2004, reporting Edwards’ financial results for the third quarter of 2004.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: October 21, 2004 |
| ||
|
| ||
|
| ||
| EDWARDS LIFESCIENCES CORPORATION | ||
|
| ||
|
| ||
| By: | /s/ Corinne H. Lyle |
|
|
| Corinne H. Lyle | |
|
| Corporate Vice President, | |
|
| Chief Financial Officer and Treasurer | |
3